AU1095595A - Gene therapy vector for the treatment of low or defective red blood cell production - Google Patents

Gene therapy vector for the treatment of low or defective red blood cell production

Info

Publication number
AU1095595A
AU1095595A AU10955/95A AU1095595A AU1095595A AU 1095595 A AU1095595 A AU 1095595A AU 10955/95 A AU10955/95 A AU 10955/95A AU 1095595 A AU1095595 A AU 1095595A AU 1095595 A AU1095595 A AU 1095595A
Authority
AU
Australia
Prior art keywords
treatment
low
red blood
gene therapy
blood cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10955/95A
Inventor
Yasuo Hamamori
Laurence H Kedes
Babru B. Samal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
University of Southern California USC
Original Assignee
Amgen Inc
University of Southern California USC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc, University of Southern California USC filed Critical Amgen Inc
Publication of AU1095595A publication Critical patent/AU1095595A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU10955/95A 1993-11-10 1994-11-09 Gene therapy vector for the treatment of low or defective red blood cell production Abandoned AU1095595A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US14987193A 1993-11-10 1993-11-10
US149871 1993-11-10
US32048094A 1994-10-07 1994-10-07
US320480 1994-10-07
PCT/US1994/013066 WO1995013376A1 (en) 1993-11-10 1994-11-09 Gene therapy vector for the treatment of low or defective red blood cell production

Publications (1)

Publication Number Publication Date
AU1095595A true AU1095595A (en) 1995-05-29

Family

ID=26847119

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10955/95A Abandoned AU1095595A (en) 1993-11-10 1994-11-09 Gene therapy vector for the treatment of low or defective red blood cell production

Country Status (4)

Country Link
EP (1) EP0737252A1 (en)
AU (1) AU1095595A (en)
CA (1) CA2183551A1 (en)
WO (1) WO1995013376A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9402857D0 (en) 1994-02-15 1994-04-06 Isis Innovation Targeting gene therapy
US6506379B1 (en) 1995-06-07 2003-01-14 Ariad Gene Therapeutics, Inc. Intramuscular delivery of recombinant AAV
US5962313A (en) 1996-01-18 1999-10-05 Avigen, Inc. Adeno-associated virus vectors comprising a gene encoding a lyosomal enzyme
US5846528A (en) * 1996-01-18 1998-12-08 Avigen, Inc. Treating anemia using recombinant adeno-associated virus virions comprising an EPO DNA sequence
US5858351A (en) * 1996-01-18 1999-01-12 Avigen, Inc. Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors
DK0888385T3 (en) 1996-03-14 2003-12-15 Genentech Inc GDNF receptor and uses thereof
AU737129B2 (en) * 1996-08-23 2001-08-09 Arch Development Corporation Long-term expression of gene products by transforming muscle cells
US5952226A (en) * 1996-11-05 1999-09-14 Modex Therapeutiques Hypoxia responsive EPO producing cells
CA2360347C (en) 1998-12-31 2013-05-07 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
US6555343B1 (en) 1999-05-07 2003-04-29 Genentech Inc. Chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same
WO2000068376A1 (en) * 1999-05-07 2000-11-16 Genentech, Inc. Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same
US6831060B2 (en) 1999-05-07 2004-12-14 Genentech, Inc. Chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same
KR20030070702A (en) * 2002-02-26 2003-09-02 사회복지법인삼성생명공익재단(삼성서울병원) Method of electroporation-mediated dna delivery and its application to the expression of erythropoietin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK173067B1 (en) * 1986-06-27 1999-12-13 Univ Washington Human erythropoietin gene, method of expression thereof in transfected cell lines, the transfected cell lines
US5538722A (en) * 1989-06-13 1996-07-23 Stanford University Isolation, growth, differentiation and genetic engineering of human muscle cells
JPH08501210A (en) * 1992-07-02 1996-02-13 ザ ソールク インスチチュート フォア バイオロジカル スタディズ Utilization of myoblasts for sustained release of gene products

Also Published As

Publication number Publication date
CA2183551A1 (en) 1995-05-18
EP0737252A1 (en) 1996-10-16
WO1995013376A1 (en) 1995-05-18

Similar Documents

Publication Publication Date Title
EP0686203A4 (en) Compounds and methods for the diagnosis, treatment and prevention of diseases of cell death
AU2552795A (en) Safe vectors for gene therapy
AU1409488A (en) Coagulation treatment of fluids
AU6194894A (en) Bile acid derivatives, processes for their preparation and the use of these compounds as medicaments
EP0690673A4 (en) Systemic gene treatment of connective tissue diseases
AU3972893A (en) Gene therapy using the intestine
AU7867994A (en) Hemofiltration of mediator-related diseases
AU699706C (en) Improved vectors for gene therapy
AU2080988A (en) Esters of 13-trans-retinoic acid
AU3022592A (en) Hydrometallurgical process for the treatment of copper-bearing ore
AU8089494A (en) Composition and method for treating blood vessel disorders of the skin using vitamin
AU4958096A (en) Process for the treatment of gases
AU6797094A (en) Cosmetic treatment of substrates
AU1095595A (en) Gene therapy vector for the treatment of low or defective red blood cell production
AU6793594A (en) Apparatus for the treatment of overbite
AU7816694A (en) Method and system for the treatment of seeds and bulbs
AU3133889A (en) Method for the treatment of the extraphyramidal side effects associated with neuroleptic therapy
AU1438295A (en) Method for treatment of papulo-pustules and comedones of the skin
AU4859596A (en) Imidazo{1,2-a}pyridines for the treatment of cns and cardiac diseases
AU2403988A (en) Processed red blood cells and process for producing the same
AU1118588A (en) Process and equipment for the rapid determination of the spermium cell count and/or living spermium count
AU1867297A (en) Gene-therapeutic nucleic acid construct, production of same and use of same in the treatment of heart disorders
AU4805093A (en) Methods for treatment of enzyme preparations
AU6336186A (en) Process for treatment of allergies
AU4172089A (en) Phosphonic acid containing cotelomers, and their use for water treatment